{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:16:29Z","timestamp":1791296189755,"version":"4.1.0"},"reference-count":68,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1596,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1365-2710.2011.01265.x","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T07:01:23Z","timestamp":1303196483000},"page":"132-139","source":"Crossref","is-referenced-by-count":33,"title":["A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia"],"prefix":"10.1155","volume":"37","author":[{"given":"K.","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Myronyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Stercula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB1|cit1","first-page":"207","article-title":"Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids","volume":"12","author":"Kidd","year":"2007","journal-title":"Alternative Medicine Review"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophrenia Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/353164a0","article-title":"Dopamine activation of the arachidonic acid cascade as a basis for D1\/D2 receptor synergism","volume":"353","author":"Piomelli","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","article-title":"Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia","volume":"137","author":"Steullet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study","volume":"33","author":"Berger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB8|cit8","volume-title":"DSM-IV-TR: Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (APA)","year":"2000"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiologic Reviews"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0193-953X(02)00030-8","article-title":"The new genetics of schizophrenia","volume":"26","author":"McDonald","year":"2003","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB11|cit11","first-page":"1","article-title":"Brain dopamine receptors in schizophrenia and tardive dyskinesia","volume":"2","author":"Seeman","year":"1985","journal-title":"Psychopharmacology Supplementum"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2003.09.010","article-title":"What\u2019s atypical about atypical antipsychotic drugs?","volume":"4","author":"Meltzer","year":"2004","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB13|cit13","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"American Family Physician"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000228994","article-title":"Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper","volume":"55","author":"Ratnayake","year":"2009","journal-title":"Annals of Nutrition and Metabolism"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1079\/PNS2001130","article-title":"Dietary essential fatty acids and brain function: a developmental perspective on mechanisms","volume":"61","author":"Wainwright","year":"2002","journal-title":"Proceedings of the Nutrition Society"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2009.01.004","article-title":"Comparative effects of DHA and EPA on cell function","volume":"122","author":"Gorjao","year":"2009","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02859265","article-title":"Essential fatty acids, DHA and human brain","volume":"72","author":"Singh","year":"2005","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2146\/ajhp080411","article-title":"Therapeutic potential of n-3 polyunsaturated fatty acids in disease","volume":"66","author":"Fetterman","year":"2009","journal-title":"American Journal of Health System Pharmacy"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3949\/ccjm.71.3.208","article-title":"Fish oil supplementation: evidence for health benefits","volume":"71","author":"Harris","year":"2004","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB23|cit23","first-page":"213","article-title":"Nutrition, brain and environment: how to have smarter babies?","volume":"40","author":"Singh","year":"2003","journal-title":"Indian Pediatrics"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-0500-1-89","article-title":"Stability of methylnicotinate in aqueous solution as utilized in the \u2018niacin patch test\u2019","volume":"1","author":"Ross","year":"2008","journal-title":"BMC research notes"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archpsyc.1994.03950080077012","article-title":"Arachidonic acid: a common link in the biology of schizophrenia?","volume":"51","author":"Peet","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB29|cit29","first-page":"495","article-title":"Increased serum phospholipase A2 activity in schizophrenia: a replication study","volume":"28","author":"Gattaz","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0006-3223(93)90157-9","article-title":"Elevated PLA2 activity in schizophrenics and other psychiatric patients","volume":"34","author":"Noponen","year":"1993","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-8993(99)01123-3","article-title":"Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia","volume":"821","author":"Ross","year":"1999","journal-title":"Brain Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-2007-1014349","article-title":"Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients","volume":"26","author":"Albers","year":"1993","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB33|cit33","first-page":"108","article-title":"[Lipid peroxidation processes in patients with schizophrenia]","volume":"89","author":"Kovaleva","year":"1989","journal-title":"Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuroimage.2006.12.023","article-title":"Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia","volume":"35","author":"Smesny","year":"2007","journal-title":"Neuroimage"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-8993(96)00134-5","article-title":"Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites","volume":"721","author":"Smalheiser","year":"1996","journal-title":"Brain Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1046\/j.1471-4159.1996.67062599.x","article-title":"Characterization of phospholipase A2 activity enriched in the nerve growth cone","volume":"67","author":"Negre-Aminou","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1046\/j.1471-4159.1996.66041532.x","article-title":"Increased neural cell adhesion molecule in the CSF of patients with mood disorder","volume":"66","author":"Poltorak","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB39|cit39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001257.pub2","article-title":"Polyunsaturated fatty acid supplementation for schizophrenia","author":"Irving","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1176\/ajp.143.7.912","article-title":"Essential fatty acid supplementation in tardive dyskinesia","volume":"143","author":"Wolkin","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"Journal of Psychiatric Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2006.03.023","article-title":"The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial","volume":"84","author":"Emsley","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1600-0447.1988.tb06388.x","article-title":"Fat consumption and schizophrenia","volume":"78","author":"Christensen","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/070674377401900406","article-title":"Prevalence of psychiatric disorders in a southern Baffin Island Eskimo settlement","volume":"19","author":"Sampath","year":"1974","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross-national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn\u2019s disease","volume":"334","author":"Belluzzi","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"349S","DOI":"10.1093\/ajcn\/71.1.349s","article-title":"n-3 fatty acid supplements in rheumatoid arthritis","volume":"71","author":"Kremer","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ajcn\/84.1.5","article-title":"n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review","volume":"84","author":"Wang","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.mco.0000214573.75062.0a","article-title":"Fish oil in the critically ill: from experimental to clinical data","volume":"9","author":"Mayer","year":"2006","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archopht.118.3.401","article-title":"Dietary fat and fish intake and age-related maculopathy","volume":"118","author":"Smith","year":"2000","journal-title":"Archives of Ophthalmology"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2008.05.016","article-title":"Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer\u2019s disease","volume":"20","author":"Boudrault","year":"2009","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ajcn\/85.4.1103","article-title":"Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study","volume":"85","author":"Beydoun","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/01.WNL.0000038345.77753.46","article-title":"Diet and risk of dementia: does fat matter?: The Rotterdam Study","volume":"59","author":"Engelhart","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.325.7370.932","article-title":"Fish, meat, and risk of dementia: cohort study","volume":"325","author":"Barberger-Gateau","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer\u2019s disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ogc.2009.10.005","article-title":"Update and critique of natural remedies as antidepressant treatments","volume":"36","author":"Mischoulon","year":"2009","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PSY.0b013e3180313a45","article-title":"Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults","volume":"69","author":"Kiecolt-Glaser","year":"2007","journal-title":"Psychosomatic Medicine"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psychres.2007.12.011","article-title":"Omega-3 deficiency associated with perinatal depression: case control study","volume":"166","author":"Rees","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1054\/plef.2000.0176","article-title":"Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids","volume":"63","author":"Simopoulos","year":"2000","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1111\/j.1365-2710.2011.01265.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"327S","DOI":"10.1093\/ajcn\/71.1.327S","article-title":"Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder","volume":"71","author":"Burgess","year":"2000","journal-title":"American Journal of Clinical Nutrition"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2011.01265.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2011.01265.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:09Z","timestamp":1671818649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2011.01265.x"}},"subtitle":["Essential fatty acids and schizophrenia"],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01265.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}